Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhIL-11 plus glucocorticoid for immune thrombocytopenia
ChiCTR-IPR-15006397Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Fujian Medical University
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oprelvekin and methylprednisolone in immune thrombocytopenia (ITP) (2 arms), sponsored by The Second Affiliated Hospital of Fujian Medical University. Primary endpoint: Platelet count. Started Jun 2015; status: recruiting.
02
Drugs
oprelvekinmethylprednisolone
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on ChiCTR-IPR-15006397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006397.